Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study, With a Vedolizumab IV Reference Arm, to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Status: Enrolling
Updated:  12/31/1969
Expertia S.A- Mautalen Salud e Investigacion
5384
mi
from 43215
Ciudad Autonoma Buenos Aires,
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study, With a Vedolizumab IV Reference Arm, to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Status: Enrolling
Updated: 12/31/1969
Expertia S.A- Mautalen Salud e Investigacion
5384
mi
from 43215
Ciudad Autonoma Buenos Aires,
Click here to add this to my saved trials
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) & Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderately Active UC
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
358
mi
from 43215
Greenville, SC
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) & Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderately Active UC
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
358
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) & Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderately Active UC
Status: Enrolling
Updated:  12/31/1969
Research Site
4510
mi
from 43215
Hradec Kralove,
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) & Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderately Active UC
Status: Enrolling
Updated: 12/31/1969
Research Site
4510
mi
from 43215
Hradec Kralove,
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1653
mi
from 43215
Scottsdale, AZ
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1653
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2099
mi
from 43215
Oakland, CA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2099
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1959
mi
from 43215
Orange, CA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1162
mi
from 43215
Denver, CO
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
554
mi
from 43215
Hartford, CT
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
792
mi
from 43215
Orlando, FL
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
797
mi
from 43215
Metairie, LA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
334
mi
from 43215
Laurel, MD
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
334
mi
from 43215
Laurel, MD
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
635
mi
from 43215
Plymouth, MN
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
635
mi
from 43215
Plymouth, MN
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
559
mi
from 43215
Rochester, MN
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
492
mi
from 43215
Great Neck, NY
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
494
mi
from 43215
New Hyde Park, NY
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
355
mi
from 43215
Rochester, NY
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
302
mi
from 43215
Asheville, NC
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
302
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
354
mi
from 43215
Durham, NC
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
152
mi
from 43215
Beaver Falls, PA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
152
mi
from 43215
Beaver Falls, PA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
619
mi
from 43215
Providence, RI
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
508
mi
from 43215
Memphis, TN
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
278
mi
from 43215
Charlottesville, VA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
278
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
1636
mi
from 43215
Federal,
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
1636
mi
from 43215
Federal,
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
450
mi
from 43215
Egg Harbor Township, NJ
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
450
mi
from 43215
Egg Harbor Township, NJ
Click here to add this to my saved trials
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
Status: Enrolling
Updated:  12/31/1969
Stanford University
2100
mi
from 43215
Stanford, CA
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
Status: Enrolling
Updated: 12/31/1969
Stanford University
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
TD-1473 for Active Ulcerative Colitis (UC)
A Phase 1b Multi-Center, Randomized, Double-Blind, Multi−Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Plasma Exposure of TD−1473 in Subjects With Moderately-to-Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Delta Research Partners, LLC
720
mi
from 43215
Monroe, LA
TD-1473 for Active Ulcerative Colitis (UC)
A Phase 1b Multi-Center, Randomized, Double-Blind, Multi−Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Plasma Exposure of TD−1473 in Subjects With Moderately-to-Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Delta Research Partners, LLC
720
mi
from 43215
Monroe, LA
Click here to add this to my saved trials